Manchester Financial Inc Mannkind Corp Transaction History
Manchester Financial Inc
- $374 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding MNKD
# of Institutions
211Shares Held
130MCall Options Held
1.81MPut Options Held
808K-
Black Rock Inc. New York, NY21.6MShares$116 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$81 Million0.0% of portfolio
-
State Street Corp Boston, MA11.9MShares$63.9 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY10.1MShares$53.9 Million4.85% of portfolio
-
Avoro Capital Advisors LLC New York, NY9MShares$48.2 Million0.49% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.38B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...